↓ Skip to main content

Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies

Overview of attention for article published in Molecular Cancer, November 2020
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies
Published in
Molecular Cancer, November 2020
DOI 10.1186/s12943-020-01282-7
Pubmed ID
Authors

Chaoting Zhang, Heyilimu Palashati, Zhuona Rong, Ningjing Lin, Luyan Shen, Ying Liu, Shance Li, Bentong Yu, Wenjun Yang, Zheming Lu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 18%
Student > Doctoral Student 2 12%
Student > Ph. D. Student 1 6%
Unspecified 1 6%
Student > Master 1 6%
Other 0 0%
Unknown 9 53%
Readers by discipline Count As %
Immunology and Microbiology 3 18%
Nursing and Health Professions 2 12%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Unspecified 1 6%
Medicine and Dentistry 1 6%
Other 0 0%
Unknown 9 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2023.
All research outputs
#7,228,396
of 25,059,640 outputs
Outputs from Molecular Cancer
#566
of 1,889 outputs
Outputs of similar age
#168,387
of 520,558 outputs
Outputs of similar age from Molecular Cancer
#11
of 24 outputs
Altmetric has tracked 25,059,640 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1,889 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 520,558 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.